Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

DoubleTree Bethesdan

Sep 23, 2019 7:00 AM - Sep 24, 2019 5:00 PM

8120 Wisconsin Avenue, , Bethesda, MD 20814 , USA

Biosimilars Conference

Session 6: What’s the Value to Patients and What Challenges Exist to Access?

Learning Objective : At the conclusion of this session, participants should be able to:
  • Describe the current environment in the United States related to patient access to biosimilars
  • Identify challenges in patient access to biosimilars including regulatory issues, payment issues, and education
  • Describe 1-2 ways that current challenges may be improved


Benjamin  Chandhok

Implications to Biosimilar Access for Patients with Arthritis

Benjamin Chandhok

Arthritis Foundation, United States

Senior Director, State Legislative Affairs

Laura  Lasiter

How Can Biosimilars Benefit Patients with Cancer and What Are Challenges to Access?

Laura Lasiter

Friends of Cancer Research, United States

Science Policy Analyst

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.